Advertisement

Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro

      Objective

      To determine the effect of 1,25(OH)2D3 and 25(OH)D3 vitamin D derivates on the growth of leiomyoma and myometrial cells in vitro.

      Design

      In vitro study.

      Setting

      Cell biology research laboratory.

      Patient(s)

      Six premenopausal women with uterine leiomyomas undergoing hysterectomy.

      Intervention(s)

      Samples of leiomyomas and normal myometrial tissue were obtained, and paired cultures were established.

      Main Outcome Measure(s)

      A colorimetric crystal violet assay to determine the effect of 1,25(OH)2D3 and 25(OH)D3 on cell growth.

      Result(s)

      In both myometrial and leiomyoma cells, 0.1 nM physiologic level of 1,25(OH)2D3 inhibited growth by 12% when compared with controls. The growth inhibition was concentration dependent; the highest concentration of 1,25(OH)2D3 (100 nM) inhibited growth by 62% in both cell types. All the differences were statistically significant. A slight stimulation (<4%) of cell proliferation was observed with the lowest 25(OH)2D3 concentrations. When treated with either a 500 nM or 1000 nM concentration of the compound, the growth of both cell types fell to approximately 50% of that of the control cultures, and the level of inhibition with the latter concentration was statistically significant.

      Conclusion(s)

      Both myometrial and leiomyoma cell growth in vitro was effectively inhibited by 1,25(OH)2D3. Vitamin D may play a role in the growth of uterine leiomyomas.

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stewart E.A.
        Uterine fibroids.
        Lancet. 2001; 357: 293-298
        • Farquhar C.M.
        • Steiner C.A.
        Hysterectomy rates in the United States 1990–1997.
        Obstet Gynecol. 2002; 99: 229-234
        • Flake G.P.
        • Andersen J.
        • Dixon D.
        Etiology and pathogenesis of uterine leiomyomas: a review.
        Environ Health Perspect. 2003; 111: 1037-1054
        • Arslan A.A.
        • Gold L.I.
        • Mital K.
        • Suen T.C.
        • Belitskaya-Levy I.
        • Tang M.S.
        • et al.
        Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review.
        Hum Reprod. 2005; 20: 852-863
        • Shushan A.
        • Ben-Bassat H.
        • Mishani E.
        • Laufer N.
        • Klein B.Y.
        • Rojansky N.
        Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050.
        Fertil Steril. 2007; 87: 127-135
        • McDonnel D.P.
        • Mangelsdorf D.J.
        • Pike J.W.
        • Haussler M.R.
        • O'Malley B.W.
        Molecular cloning of complementary DNA encoding the avian receptor for vitamin D.
        Science. 1987; 235: 1214-1217
        • Baker A.R.
        • McDonnell D.P.
        • Hughes M.
        • Crisp T.M.
        • Mangelsdorf D.J.
        • Haussler M.R.
        • et al.
        Cloning and expression of full-length cDNA encoding human vitamin D receptor.
        Proc Natl Acad Sci USA. 1988; 85: 3294-3298
        • Vienonen A.
        • Miettinen S.
        • Bläuer M.
        • Martikainen P.
        • Tomas E.
        • Heinonen P.K.
        • et al.
        Expression of nuclear receptors and cofactors in human endometrium and myometrium.
        J Soc Gynecol Investig. 2004; 11: 104-112
        • Schwartz G.G.
        • Wang M.H.
        • Zang M.
        • Singh R.K.
        • Siegal G.P.
        1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
        Cancer Epidemiol Biomarkers Prev. 1997; 6: 727-732
        • Lokeshwar B.L.
        • Schwartz G.G.
        • Selzer M.G.
        • Burnstein K.L.
        • Zhuang S.H.
        • Block N.L.
        • et al.
        Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089.
        Cancer Epidemiol Biomarkers Prev. 1999; 8: 241-248
        • Mantell D.J.
        • Owens P.E.
        • Bundred N.J.
        • Mawer E.B.
        • Canfield A.E.
        1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo.
        Circ Res. 2000; 87: 214-220
        • Ylikomi T.
        • Laaksi I.
        • Lou Y.R.
        • Martikainen P.
        • Miettinen S.
        • Pennanen P.
        • et al.
        Antiproliferative action of vitamin D.
        Vitam Horm. 2002; 64: 357-406
        • Wang Q.M.
        • Jones J.B.
        • Studzinski G.P.
        Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.
        Cancer Res. 1996; 56: 264-267
        • Simboli-Campbell M.
        • Narvaez C.J.
        • van Weelden K.
        • Tenniswood M.
        • Welsh J.
        Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
        Breast Cancer Res Treat. 1997; 42: 31-41
        • Zhuang S.H.
        • Burnstein K.L.
        Antiproliferative effect of 1 alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCap involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
        Endocrinology. 1998; 139: 1197-1207
        • Hager G.
        • Formanek M.
        • Gedlicka C.
        • Thurnher D.
        • Knerer B.
        • Kornfehl J.
        1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck.
        Acta Otolaryngol. 2001; 121: 103-109
        • Audo I.
        • Darjatmoko S.R.
        • Schlamp C.L.
        • Lokken J.M.
        • Lindstrom M.J.
        • Albert D.M.
        • et al.
        Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma.
        Invest Ophthalmol Vis Sci. 2003; 44: 4192-4199
        • Colston K.W.
        • Hansen C.M.
        Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.
        Endocr Relat Cancer. 2002; 9: 45-49
        • Welsh J.
        • Simboli-Campbell M.
        • Narvaez C.J.
        • Tenniswood M.
        Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells.
        Adv Exp Med Biol. 1995; 375: 45-52
        • Kueng W.
        • Silber E.
        • Eppenberger U.
        Quantification of cells cultured on 96-well plates.
        Anal Biochem. 1989; 182: 16-19
        • Lou Y.-R.
        • Laaksi I.
        • Syvälä H.
        • Bläuer M.
        • Tammela T.L.J.
        • Ylikomi T.
        • et al.
        25-Hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells.
        FASEB J. 2004; 18: 332-334
        • Barreto A.M.
        • Schwarz G.G.
        • Woodruff R.
        • Cramer S.D.
        25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
        Cancer Epidemiol Biomarkers Prev. 2000; 9: 265-270
        • Itin P.H.
        • Pittelkow M.R.
        • Kumar R.
        Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium.
        Endocrinology. 1994; 135: 1793-1798
        • Miettinen S.
        • Ahonen M.
        • Lou Y.-R.
        • Manninen T.
        • Tuohimaa P.
        • Syvälä H.
        • et al.
        Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells.
        Int J Cancer. 2004; 108: 367-373
        • Munker R.
        • Norman A.
        • Koeffler H.P.
        Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.
        J Clin Invest. 1986; 78: 424-430
        • Love-Schimenti C.D.
        • Gibson D.F.
        • Ratnam A.V.
        • Bikle D.D.
        Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
        Cancer Res. 1996; 56: 2789-2794
        • Zehnder D.
        • Bland R.
        • Williams M.C.
        • McNinch R.W.
        • Howie A.J.
        • Stewart P.M.
        • et al.
        Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase.
        J Clin Endocrinol Metab. 2001; 86: 888-894
        • Evans K.N.
        • Bulmer J.N.
        • Kilby M.D.
        • Hewison M.
        Vitamin D and placental-decidual function.
        J Soc Gynecol Investig. 2004; 5: 263-271
        • Shushan A.
        • Rojansky N.
        • Laufer N.
        • Klein B.Y.
        • Shlomai Z.
        • Levitzki R.
        • et al.
        The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.
        Hum Reprod. 2004; 19: 1957-1967
        • Gillies R.J.
        • Didier N.
        • Denton M.
        Determination of cell number in monolayer cultures.
        Anal Biochem. 1986; 159: 109-113
        • Palmberg L.
        • Thyberg J.
        Uterine smooth muscle cells in primary culture. Alterations in fine structure, cytoskeletal organization and growth characteristics.
        Cell Tissue Res. 1986; 246: 253-262
        • Virtanen I.
        • Lehto V.-P.
        • Lehtonen E.
        • Vartio T.
        • Stenman S.
        • Kurki P.
        • et al.
        Expression of intermediate filaments in cultured cells.
        J Cell Sci. 1981; 50: 45-63
        • Broaddus R.R.
        • Xie S.
        • Hsu C.-J.
        • Wang J.
        • Zhang S.
        • Zou C.
        The chemopreventive agents 4-HPR snd DFMO inhibit growth and induce apoptosis in uterine leiomyomas.
        Am J Obstet Gynecol. 2004; 190: 686-692
        • Yamada T.
        • Nakago S.
        • Kurachi O.
        • Wang J.
        • Takekida S.
        • Matsuo H.
        • et al.
        Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
        Hum Reprod. 2004; 19: 815-821
        • Severino M.F.
        • Murray M.J.
        • Brandon D.D.
        • Clinton G.M.
        • Burry K.A.
        • Novy M.
        Rapid loss of estrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.
        Mol Hum Reprod. 1996; 11: 823-828